Meeting
2023 ASCO Annual Meeting
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).
Authors
Davide Soldato
IRCCS Ospedale Policlinico San Martino, Università degli Studi di Genova, Genova, Italy
Davide Soldato , Eva Blondeaux , Marco Bruzzone , Silvia Mura , Michelino De Laurentiis , Anna Turletti , Sabino De Placido , Giancarlo Bisagni , Anita Rimanti , Andrea Michelotti , Alessandra Fabi , Antonio Russo , Stefania Gori , Antonio Durando , Guilherme Nader Marta , Evandro de Azambuja , Antonio Di Meglio , Ines Vaz-Luis , Matteo Lambertini , Lucia Del Mastro
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Health Promotion/Behaviors
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12067)
DOI
10.1200/JCO.2023.41.16_suppl.12067
Abstract #
12067
Poster Bd #
435
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Impact of body mass index (BMI) on the prognosis of women with high-risk early breast cancer (BC) receiving adjuvant chemotherapy (CT).
First Author: Alessandra Gennari
Poster
2022 ASCO Genitourinary Cancers Symposium
Quantifying absolute benefit of adjuvant treatments in renal cell carcinoma: A systematic review and network-meta-analysis.
First Author: Qurat Ul Ain Riaz Sipra
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Periop-01: A randomized controlled trial of extended perioperative tinzaparin to improve disease-free survival in patients with resectable colorectal cancer.
First Author: Rebecca Ann C Auer
Poster
2020 ASCO Virtual Scientific Program
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomized controlled trials.
First Author: Ulrich Ronellenfitsch